NCT01245894View on ClinicalTrials.gov

Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2010

Conditions
Myocardial Infarction [C14.907.585.500]
Interventions
DRUG

Low-dose Rosuvastatin

Rosuvastatin 5mg/day for one year

DRUG

High-dose Rosuvastatin

Rosuvastatin 40mg/day for one year

Trial Locations (1)

5000

Department of Cardiology, Odense University Hospital, Odense

All Listed Sponsors
lead

Odense University Hospital

OTHER

NCT01245894 - Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment | Biotech Hunter | Biotech Hunter